Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

A Rating Scale for Drug-Induced Akathisia

1989 • 2,135 citations

The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome

1984 • 1,671 citations

The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations

1989 • 1,384 citations

Risperidone in the treatment of schizophrenia

1994 • 1,205 citations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 • 1,143 citations

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

1996 • 1,047 citations

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 • 906 citations

A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

1993 • 884 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1994 • 592 citations

Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol

1995 • 558 citations

CONDITIONS PREDISPOSING TO SUICIDE

1977 • 510 citations

The Mechanism of Action of Novel Antipsychotic Drugs

1991 • 410 citations

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1996 • 387 citations

Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders

1997 • 327 citations

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1996 • 315 citations

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.

1994 • 304 citations

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1997 • 302 citations

Effects of Psychotropic Drugs on Human Erection and Ejaculation

1989 • 298 citations

Schizophrenia

1996 • 270 citations

The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.

1992 • 264 citations

Antipsychotic agents antagonize non-competitiveN-methyl-d-aspartate antagonist-induced behaviors

1995 • 248 citations

Sexual Dysfunction and Plasma Prolactin Levels in Neuroleptic-treated Schizophrenic Outpatients

1982 • 231 citations

Sexual dysfunction in male schizophrenic patients.

1995 • 217 citations

An economic evaluation of schizophrenia-1991

1995 • 203 citations

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1995 • 194 citations

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients

1995 • 146 citations

Effects of Olanzapine on Regional C-Fos Expression in Rat Forebrain

1996 • 140 citations

Extrapyramidal Symptoms in Patients Treated With Risperidone

1997 • 129 citations

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study

1996 • 124 citations

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1994 • 112 citations

The current status of neuroleptic therapy.

1989 • 108 citations

Causes of Neuroleptic Noncompliance

1986 • 81 citations

Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule

1994 • 64 citations

Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat

1995 • 57 citations

The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine

1995 • 31 citations

Deleted Work

1955 • 0 citations